Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Disorders.
2 other identifiers
observational
600
1 country
1
Brief Summary
Background: People with hearing, balance, and taste, smell, voice, speech, language, and other Ear, Nose, and Throat (ENT) disorders may seek treatment at the National Institute on Deafness and Other Communication Disorders (NIDCD). Some of these people may benefit from enrolling in the NIDCD intramural research program to receive their care. Enrolling will also allow investigators to collect participants clinical data and specimens for future research. Objective: This natural history study has 2 goals: (1) to collect data and specimens that may be used for research; and (2) to evaluate participants who may be candidates for other research studies. Eligibility: People aged 2 years or older with a hearing, balance, and communication disorder. Those at risk or who are suspected of having such a disorder are also eligible. Design: Participants will be screened. Their medical records will be reviewed. Participants will agree to have their medical data used for research. Specimens such as blood or other tissue samples may also be used for research. All data and specimens will be collected during their routine care visits. All tests done will be the normal care for each participant s condition. No tests will be done solely for research. Some of these tests may require blood or tissue samples. Some may use special tools to test hearing and balance. Some may test heart or lung function. These tests may also include different types of imaging scans. All tests will be explained. Participants may ask questions at any time. Participants may remain in this study for up to 2 years. If they need further care, they may sign a new consent. ...
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 31, 2022
CompletedFirst Posted
Study publicly available on registry
January 4, 2023
CompletedStudy Start
First participant enrolled
March 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2032
April 28, 2026
April 24, 2026
3.4 years
December 31, 2022
April 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Clinical data collection
To collect clinical data or specimens generated in the diagnosis and treatment of hearing, balance and communication disorders
Ongoing
Evaluation for clinical studies
To evaluate patients to determine candidacy for intramural clinical studies
Ongoing
Study Arms (1)
Patients
Patients at risk, suspected of having, have a history of, or currently have a diagnosed hearing, balance or communication disorder.
Eligibility Criteria
Patients at risk, suspected of having, have a history of, or currently have a diagnosed hearing, balance and communication disorders referred to NIDCD Clinical Investigators by the Intramural Consult Service or community providers
You may qualify if:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Patients must be age 2 years or older if procedures or treatment are required.
- Patients at risk, suspected of having, have a history of, or currently have a diagnosed hearing, balance, taste, smell, voice, speech, language, and other ENT disorder.
- An NIDCD clinical investigator and PI determines it is in the interest of the patient/individual and NIDCD CRP for the subject to undergo consult, treatment or follow-up at the NIDCD/NIH
- Patient or their Legally Authorized Representative is able to provide informed consent. The consent form will be signed by parents or guardians of patients under the age of 18.
- A subset of enrolled participants with known or suspected PIEZO2-related sensory dysfunction may be asked to participate in the remote taste and oral somatosensory testing procedures. Participation in this component is optional and not required for enrollment or continued participation in the parent protocol.
You may not qualify if:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Candidates who in the opinion of the PI and clinical team have medical or unstable conditions for which NIDCD and CC consultative services are unable to provide or support optimal care
- Active oral sores, open cuts, or significant oral pain
- Recent oral surgery or dental procedures within the past 7 days
- Known allergy or hypersensitivity to tannins or polyphenols
- Acute upper respiratory infection or conditions that may interfere with taste perception
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joshua M Levy, M.D.
National Institute on Deafness and Other Communication Disorders (NIDCD)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 31, 2022
First Posted
January 4, 2023
Study Start
March 8, 2023
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
December 1, 2032
Last Updated
April 28, 2026
Record last verified: 2026-04-24